Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach

Prolonged B-cell depletion due to anti-CD20 monoclonal antibody (mAbs) therapy impairs the adaptive immune response, causing severe manifestations during COronaVIrus Disease-2019 (COVID-19). The cases of two patients under anti-CD20 therapy who experienced prolonged and severe COVID-19 successfully...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Abramo, Alessandra, Vita, Serena, Maffongelli, Gaetano, Mariano, Andrea, Agrati, Chiara, Castilletti, Concetta, Goletti, Delia, Ippolito, Giuseppe, Nicastri, Emanuele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065233/
https://www.ncbi.nlm.nih.gov/pubmed/33901654
http://dx.doi.org/10.1016/j.ijid.2021.04.068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065233/
https://www.ncbi.nlm.nih.gov/pubmed/33901654
http://dx.doi.org/10.1016/j.ijid.2021.04.068

Ejemplares similares